Biblio

Export 1310 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
K. C Kim, Lee, Y. Rui, Ong, L., Gold, M., Kalali, A., and Sarkar, J., Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures., J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization., Neurology, vol. 74, no. 3, pp. 201-9, 2010.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta., Neuron, vol. 78, no. 4, pp. 631-43, 2013.
F. El Gaamouch, Jing, P., Xia, J., and Cai, D., Alzheimer's Disease Risk Genes and Lipid Regulators., J Alzheimers Dis, vol. 53, no. 1, pp. 15-29, 2016.
D. Barthold, Gibbons, L. E., Marcum, Z. A., Gray, S. L., C Keene, D., Grabowski, T. J., Postupna, N., Larson, E. B., and Crane, P. K., Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort., J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
D. Barthold, Gibbons, L. E., Marcum, Z. A., Gray, S. L., C Keene, D., Grabowski, T. J., Postupna, N., Larson, E. B., and Crane, P. K., Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort., J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
D. Barthold, Gibbons, L. E., Marcum, Z. A., Gray, S. L., C Keene, D., Grabowski, T. J., Postupna, N., Larson, E. B., and Crane, P. K., Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort., J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
E. Wang, Zhu, H., Wang, X., Gower, A., Wallack, M., Blusztajn, J. Krzysztof, Kowall, N., and Qiu, W. Qiao, Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
C. - H. Yun, Lee, H. - Y., Lee, S. Ku, Kim, H., Seo, H. Suk, Bang, S. Ae, Kim, S. Eun, Greve, D. N., Au, R., Shin, C., and Thomas, R. J., Amyloid Burden in Obstructive Sleep Apnea., J Alzheimers Dis, vol. 59, no. 1, pp. 21-29, 2017.
I. Gureviciene, Gurevicius, K., Mugantseva, E., Kislin, M., Khiroug, L., and Tanila, H., Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β., J Alzheimers Dis, vol. 55, no. 1, pp. 147-157, 2017.
I. Gureviciene, Gurevicius, K., Mugantseva, E., Kislin, M., Khiroug, L., and Tanila, H., Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β., J Alzheimers Dis, vol. 55, no. 1, pp. 147-157, 2017.
G. Rolfseng Grøntvedt, Lauridsen, C., Berge, G., White, L. R., Salvesen, Ø., Bråthen, G., and Sando, S. Botne, The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up., J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
A. Tiiman, Jelic, V., Jarvet, J., Järemo, P., Bogdanovic, N., Rigler, R., Terenius, L., Gräslund, A., and Vukojević, V., Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis., J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
R. M. Nisbet and Götz, J., Amyloid-β and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies., J Alzheimers Dis, vol. 64, no. s1, pp. S517-S527, 2018.
D. D. Quintana, Garcia, J. A., Anantula, Y., Rellick, S. L., Engler-Chiurazzi, E. B., Sarkar, S. N., Brown, C. M., and Simpkins, J. W., Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells., J Alzheimers Dis, vol. 75, no. 1, pp. 119-138, 2020.
Y. Zhang, Guo, O., Huo, Y., Wang, G., and Man, H. - Y., Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 4, pp. 1789-1801, 2018.
M. Abdullah, Takase, H., Nunome, M., Enomoto, H., Ito, J. - I., Gong, J. - S., and Michikawa, M., Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation., J Alzheimers Dis, vol. 53, no. 4, pp. 1433-41, 2016.
L. - J. Zuo, Guo, P., Liu, L., Yu, S. - Y., Lian, T. - H., Yu, Q. - J., Hu, Y., Jin, Z., Wang, R. - D., Piao, Y. - S., Li, L. - X., Wang, Y. - J., Wang, X. - M., and Zhang, W., Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction., J Alzheimers Dis, vol. 66, no. 2, pp. 789-799, 2018.
F. Wang, Xu, J., Xu, S. - J., Guo, J. - J., Wang, F., and Wang, Q. - W., Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics., J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
H. Zhang, Chen, K., Wang, N., Zhang, D., Yang, Q., Zhang, Q., Liu, P., Wan, M., Gong, C., Hong, X., Qiu, W., Qian, X., Chen, Y., and Ma, C., Analysis of Brain Donors' Demographic and Medical Characteristics to Facilitate the Construction of a Human Brain Bank in China., J Alzheimers Dis, vol. 66, no. 3, pp. 1245-1254, 2018.
R. Fenoll, Pujol, J., Esteba-Castillo, S., de Sola, S., Ribas-Vidal, N., García-Alba, J., Sánchez-Benavides, G., Martínez-Vilavella, G., Deus, J., Dierssen, M., Novell-Alsina, R., and de la Torre, R., Anomalous White Matter Structure and the Effect of Age in Down Syndrome Patients., J Alzheimers Dis, vol. 57, no. 1, pp. 61-70, 2017.
C. C. Hays, Zlatar, Z. Z., Meloy, M. J., Osuna, J., Liu, T. T., Galasko, D. R., and Wierenga, C. E., Anterior Cingulate Structure and Perfusion Is Associated with Cerebrospinal Fluid Tau Among Cognitively Normal Older Adult APOEɛ4 Carriers., J Alzheimers Dis, vol. 73, no. 1, pp. 87-101, 2020.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies., Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies., Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies., Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.

Pages